Business · 05/06/2024Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance for Bioresearch Monitoring Inspections
The FDA has issued a draft guidance to describe processes and practices for bioresearch monitoring inspections, in compliance with the Food and Drug Omnibus Reform Act of 2022.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →